Review



yap1 inhibitor verteporfin  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress yap1 inhibitor verteporfin
    Yap1 Inhibitor Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 333 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pm42048035-93-7-14?v=MedChemExpress
    Average 96 stars, based on 333 article reviews
    yap1 inhibitor verteporfin - by Bioz Stars, 2026-07
    96/100 stars

    Images



    Similar Products

    96
    MedChemExpress yap1 inhibitor verteporfin
    Yap1 Inhibitor Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pm42048035-93-7-14?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    yap1 inhibitor verteporfin - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    86
    Valeant Pharmaceuticals visudyne
    Visudyne, supplied by Valeant Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/us12655202-9-12-13?v=Valeant+Pharmaceuticals
    Average 86 stars, based on 1 article reviews
    visudyne - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Novartis verteporfin
    Verteporfin, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pmc13162733-7-0-12?v=Novartis
    Average 86 stars, based on 1 article reviews
    verteporfin - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Quantum Dot Inc verteporfin
    The photosensitizer <t>verteporfin</t> has an optimal cytosolic distribution in vitro. ( a ) L3.6pl and ( b ) MiaPaCa-2 cell cytosolic distribution of the photosensitizer. Images acquired by CLM after adding a dose of 2 µM and after a 2-hour incubation (Scale bar: 25 µm, white). Cell nuclei were visualized with Hoechst 33342 (blue signal) and the fluorescent photosensitizer cytosolic distribution is observed in green.
    Verteporfin, supplied by Quantum Dot Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pmc13135349-192-21-22?v=Quantum+Dot+Inc
    Average 86 stars, based on 1 article reviews
    verteporfin - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    96
    MedChemExpress yap inhibitor verteporfin
    The photosensitizer <t>verteporfin</t> has an optimal cytosolic distribution in vitro. ( a ) L3.6pl and ( b ) MiaPaCa-2 cell cytosolic distribution of the photosensitizer. Images acquired by CLM after adding a dose of 2 µM and after a 2-hour incubation (Scale bar: 25 µm, white). Cell nuclei were visualized with Hoechst 33342 (blue signal) and the fluorescent photosensitizer cytosolic distribution is observed in green.
    Yap Inhibitor Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pm42048860-69-2-6?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    yap inhibitor verteporfin - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress verteporfin
    The photosensitizer <t>verteporfin</t> has an optimal cytosolic distribution in vitro. ( a ) L3.6pl and ( b ) MiaPaCa-2 cell cytosolic distribution of the photosensitizer. Images acquired by CLM after adding a dose of 2 µM and after a 2-hour incubation (Scale bar: 25 µm, white). Cell nuclei were visualized with Hoechst 33342 (blue signal) and the fluorescent photosensitizer cytosolic distribution is observed in green.
    Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pm42035970-58-25-28?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    verteporfin - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    95
    Tocris verteporfin
    The photosensitizer <t>verteporfin</t> has an optimal cytosolic distribution in vitro. ( a ) L3.6pl and ( b ) MiaPaCa-2 cell cytosolic distribution of the photosensitizer. Images acquired by CLM after adding a dose of 2 µM and after a 2-hour incubation (Scale bar: 25 µm, white). Cell nuclei were visualized with Hoechst 33342 (blue signal) and the fluorescent photosensitizer cytosolic distribution is observed in green.
    Verteporfin, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/verteporfin/pm42014719-310-11-12?v=Tocris
    Average 95 stars, based on 1 article reviews
    verteporfin - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    Image Search Results


    The photosensitizer verteporfin has an optimal cytosolic distribution in vitro. ( a ) L3.6pl and ( b ) MiaPaCa-2 cell cytosolic distribution of the photosensitizer. Images acquired by CLM after adding a dose of 2 µM and after a 2-hour incubation (Scale bar: 25 µm, white). Cell nuclei were visualized with Hoechst 33342 (blue signal) and the fluorescent photosensitizer cytosolic distribution is observed in green.

    Journal: International Journal of Nanomedicine

    Article Title: Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma

    doi: 10.2147/IJN.S545161

    Figure Lengend Snippet: The photosensitizer verteporfin has an optimal cytosolic distribution in vitro. ( a ) L3.6pl and ( b ) MiaPaCa-2 cell cytosolic distribution of the photosensitizer. Images acquired by CLM after adding a dose of 2 µM and after a 2-hour incubation (Scale bar: 25 µm, white). Cell nuclei were visualized with Hoechst 33342 (blue signal) and the fluorescent photosensitizer cytosolic distribution is observed in green.

    Article Snippet: Spectral analysis confirmed a strong overlap between RLuc8 emission and QDots excitation , enabling effective energy absorption and transfer to activate verteporfin (QDot excitation/emission in Figure S2c ).

    Techniques: In Vitro, Incubation

    BL-PDT induces cell death in PDAC cells. ( a ) The excitation spectra of the photosensitizer matches the emission spectra of the QDots. Study of verteporfin cytotoxicity in ( b ) L3.pl6 and ( c ) Mia PaCa-2 cells after 4h of incubation at increasing concentrations (0–16 µM) of verteporfin. ( d ) SI-NCs cytotoxicity was evaluated by MTT in L3.6pl cells after 4h of incubation, with an IC 50 calculated of 4.24 pmol. Statistical analyses: ANOVA with a Dunnett’s test. Cell viability analysis following BL-PDT in ( e ) L3.6pl and ( f ) MiaPaCa-2 cells. Doses: Verteporfin (4 µM); SI-NCs (1 pmol); CTZ (20 µg/mL). Bars representing: 1–8 controls and 9 BL-PDT treatment. All data are expressed in terms of dose response and/or concentration/viability. Data are presented as means ± s.d. (at least n = 3 per group). Statistical analyses p-values: ns (non-significant) ** (p < 0.01), *** (p < 0.001) and **** (p < 0.0001).

    Journal: International Journal of Nanomedicine

    Article Title: Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma

    doi: 10.2147/IJN.S545161

    Figure Lengend Snippet: BL-PDT induces cell death in PDAC cells. ( a ) The excitation spectra of the photosensitizer matches the emission spectra of the QDots. Study of verteporfin cytotoxicity in ( b ) L3.pl6 and ( c ) Mia PaCa-2 cells after 4h of incubation at increasing concentrations (0–16 µM) of verteporfin. ( d ) SI-NCs cytotoxicity was evaluated by MTT in L3.6pl cells after 4h of incubation, with an IC 50 calculated of 4.24 pmol. Statistical analyses: ANOVA with a Dunnett’s test. Cell viability analysis following BL-PDT in ( e ) L3.6pl and ( f ) MiaPaCa-2 cells. Doses: Verteporfin (4 µM); SI-NCs (1 pmol); CTZ (20 µg/mL). Bars representing: 1–8 controls and 9 BL-PDT treatment. All data are expressed in terms of dose response and/or concentration/viability. Data are presented as means ± s.d. (at least n = 3 per group). Statistical analyses p-values: ns (non-significant) ** (p < 0.01), *** (p < 0.001) and **** (p < 0.0001).

    Article Snippet: Spectral analysis confirmed a strong overlap between RLuc8 emission and QDots excitation , enabling effective energy absorption and transfer to activate verteporfin (QDot excitation/emission in Figure S2c ).

    Techniques: Incubation, Concentration Assay

    PDT treatment efficiently induces necrosis and apoptosis in Panc354PDX orthotopic tumors. ( a ) By IVIS analysis, SI-NCs (50 pmol i.p.) bioluminescence was observed at the tumor site (pancreas) 15 minutes after CTZ (5 nmol i.v.) injection. Images are shown for control (negative-control), sham (vehicle-control) and BL-PTD (positive-control) mice (n=5 mice per group). For the control group, PBS was injected. The therapy BL-PDT group consisted of mice treated with the complete BL-PDT treatment [verteporfin (PS) + SI-NCs + substrate (CTZ)]. The sham group consisted of mice treated with the photosensitizer and the SI-NCs without the substrate addition (no BL-PDT treatment). The black arrow indicates the site of injection, and the red circle marks the location of the tumor. ( b ) Mean ± s.d. of tumor (left) and peritoneal metastasis (right) weights in control, sham and BL-PTD groups, observing a tendency for reduction in the BL-PDT group. ( c ) Representative images of hematoxylin and eosin (H&E)-stained histological sections of tumors (3 µm) from the three experimental groups (control, sham and BL-PDT) from ( a ). ( d ) H&E-stained sections for each mouse were prepared, digitalized and used to evaluate the percentage of necrosis in the tumors. Data are presented as means ± s.d. of the % necrotic area/total tumor area. ( e ) Additional serial sections were used for IHC analysis of the number of PCNA-positive cells. Data are presented as means ± s.d. of the area of PCNA+ cells in representative sections from the control, sham and BL-PDT groups. ( f ) Apoptotic events in tumors were analyzed using the TUNEL assay, where images were captured by fluorescence microscopy. Nuclei were stained with Hoechst 33342 (blue), and TUNEL staining is shown in green (Zoom: 25X). ( g ) Positive green-fluorescent events for TUNEL were quantified in the control, sham and BL-PDT groups. Data are presented as means ± s.d. (at least n = 3 per group). Statistical analyses p-value meaning: ns (non-significant) * (p < 0.05), ** (p < 0.01).

    Journal: International Journal of Nanomedicine

    Article Title: Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma

    doi: 10.2147/IJN.S545161

    Figure Lengend Snippet: PDT treatment efficiently induces necrosis and apoptosis in Panc354PDX orthotopic tumors. ( a ) By IVIS analysis, SI-NCs (50 pmol i.p.) bioluminescence was observed at the tumor site (pancreas) 15 minutes after CTZ (5 nmol i.v.) injection. Images are shown for control (negative-control), sham (vehicle-control) and BL-PTD (positive-control) mice (n=5 mice per group). For the control group, PBS was injected. The therapy BL-PDT group consisted of mice treated with the complete BL-PDT treatment [verteporfin (PS) + SI-NCs + substrate (CTZ)]. The sham group consisted of mice treated with the photosensitizer and the SI-NCs without the substrate addition (no BL-PDT treatment). The black arrow indicates the site of injection, and the red circle marks the location of the tumor. ( b ) Mean ± s.d. of tumor (left) and peritoneal metastasis (right) weights in control, sham and BL-PTD groups, observing a tendency for reduction in the BL-PDT group. ( c ) Representative images of hematoxylin and eosin (H&E)-stained histological sections of tumors (3 µm) from the three experimental groups (control, sham and BL-PDT) from ( a ). ( d ) H&E-stained sections for each mouse were prepared, digitalized and used to evaluate the percentage of necrosis in the tumors. Data are presented as means ± s.d. of the % necrotic area/total tumor area. ( e ) Additional serial sections were used for IHC analysis of the number of PCNA-positive cells. Data are presented as means ± s.d. of the area of PCNA+ cells in representative sections from the control, sham and BL-PDT groups. ( f ) Apoptotic events in tumors were analyzed using the TUNEL assay, where images were captured by fluorescence microscopy. Nuclei were stained with Hoechst 33342 (blue), and TUNEL staining is shown in green (Zoom: 25X). ( g ) Positive green-fluorescent events for TUNEL were quantified in the control, sham and BL-PDT groups. Data are presented as means ± s.d. (at least n = 3 per group). Statistical analyses p-value meaning: ns (non-significant) * (p < 0.05), ** (p < 0.01).

    Article Snippet: Spectral analysis confirmed a strong overlap between RLuc8 emission and QDots excitation , enabling effective energy absorption and transfer to activate verteporfin (QDot excitation/emission in Figure S2c ).

    Techniques: Injection, Control, Negative Control, Positive Control, Staining, TUNEL Assay, Fluorescence, Microscopy